Deficiency in hepatic ATP-citrate lyase affects VLDL-triglyceride mobilization and liver fatty acid composition in mice

Journal of Lipid Research

Volumn 51, Issue 9, 2010, Pages 2516-2526

  Wang, Qiong ^a,b   Li, Shoufeng ^a   Jiang, Lei ^a,c   Zhou, Yunhua ^a   Li, Zi ^a   Shao, Mengle ^a   Li, Wenjun ^a   Liu, Yong ^a  

^a UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Apolipoprotein B; Diet induced obesity; Hypotriglyceridemia

Indexed keywords

ADENOSINE TRIPHOSPHATE CITRATE LYASE; APOLIPOPROTEIN B; APOLIPOPROTEIN B100; APOLIPOPROTEIN B48; FATTY ACID; MALONYL COENZYME A; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADENOSINE TRIPHOSPHATE CITRATE LYASE DEFICIENCY; ADENOVIRUS; ANIMAL TISSUE; ARTICLE; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; DISORDERS OF LIPID AND LIPOPROTEIN METABOLISM; ENZYME DEFICIENCY; FAT INTAKE; GENE EXPRESSION; HYPOTRIGLYCERIDEMIA; LIPID COMPOSITION; LIPID DIET; LIPID METABOLISM; LIPID STORAGE; LIPOGENESIS; LOW FAT DIET; MALE; MOUSE; NONHUMAN; NUTRITIONAL STATUS; OBESITY; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA INTERFERENCE;

ANIMALS; ATP CITRATE (PRO-S)-LYASE; DIET; FATTY ACID SYNTHETASE COMPLEX; FATTY ACIDS; LIPOPROTEINS, VLDL; LIVER; MALE; MICE; MICE, INBRED C57BL; TRIGLYCERIDES;

EID: 77956851379     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M003335     Document Type: Article

References (44)

1. Wakil, S. J., J. K. Stoops, and V. C. Joshi. 1983. Fatty acid synthesis and its regulation. Annu. Rev. Biochem. 52: 537-579.
2. Kaplan, R. S., J. A. Mayor, N. Johnston, and D. L. Oliveira. 1990. Purification and characterization of the reconstitutively active tricarboxylate transporter from rat liver mitochondria. J. Biol. Chem. 265: 13379-13385.
3. Srere, P. A. 1959. The citrate cleavage enzyme. I. Distribution and purification. J. Biol. Chem. 234: 2544-2547.
4. Thampy, K. G., and A. G. Koshy. 1991. Purification, characterization, and ontogeny of acetyl-CoA carboxylase isozyme of chick embryo brain. J. Lipid Res. 32: 1667-1673.
5. Ntambi, J. M., and M. Miyazaki. 2003. Recent insights into stearoyl- CoA desaturase-1. Curr. Opin. Lipidol. 14: 255-261.
6. Havel, R. J., and J. P. Kane. 1975. Quantification of triglyceride transport in blood plasma: a critical analysis. Fed. Proc. 34: 2250-2257.
7. Lewis, G. F., A. Carpentier, K. Adeli, and A. Giacca. 2002. Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes. Endocr. Rev. 23: 201-229.
8. Browning, J. D., and J. D. Horton. 2004. Molecular mediators of hepatic steatosis and liver injury. J. Clin. Invest. 114: 147-152.
9. Donnelly, K. L., C. I. Smith, S. J. Schwarzenberg, J. Jessurun, M. D. Boldt, and E. J. Parks. 2005. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J. Clin. Invest. 115: 1343-1351.
10. Soukas, A., P. Cohen, N. D. Socci, and J. M. Friedman. 2000. Leptin-specific patterns of gene expression in white adipose tissue. Genes Dev. 14: 963-980.
11. Cohen, P., M. Miyazaki, N. D. Socci, A. Hagge-Greenberg, W. Liedtke, A. A. Soukas, R. Sharma, L. C. Hudgins, J. M. Ntambi, and J. M. Friedman. 2002. Role for stearoyl-CoA desaturase-1 in leptin-mediated weight loss. Science. 297: 240-243.
12. Lin, J., R. Yang, P. T. Tarr, P-H. Wu, C. Handschin, S. Li, W. Yang L. Pei, M. Uldry, P. Tontonoz, et al. 2005. Hyperlipidemic effects of dietary saturated fats mediated through PGC-1[beta] coactivation of SREBP. Cell. 120: 261-273. (Pubitemid 40174768)
13. Jiang, L., Q. Wang, Y. Yu, F. Zhao, P. Huang, R. Zeng, R. Z. Qi, W. Li, and Y. Liu. 2009. Leptin contributes to the adaptive responses of mice to high-fat diet intake through suppressing the lipogenic pathway. PLoS ONE. 4: e6884.
14. Ntambi, J. M., M. Miyazaki, J. P. Stoehr, H. Lan, C. M. Kendziorski B. S. Yandell, Y. Song, P. Cohen, J. M. Friedman, and A. D. Attie 2002. Loss of stearoyl-CoA desaturase-1 function protects mice against adiposity. Proc. Natl. Acad. Sci. USA. 99: 11482-11486.
15. Abu-Elheiga, L., W. Oh, P. Kordari, and S. J. Wakil. 2003. Acetyl- CoA carboxylase 2 mutant mice are protected against obesity and diabetes induced by high-fat/high-carbohydrate diets. Proc. Natl. Acad. Sci. USA. 100: 10207-10212.
16. Jiang, G., Z. Li, F. Liu, K. Ellsworth, Q. Dallas-Yang, M. Wu, J. Ronan C. Esau, C. Murphy, D. Szalkowski, et al. 2005. Prevention of obesity in mice by antisense oligonucleotide inhibitors of stearoyl-CoA desaturase- 1. J. Clin. Invest. 115: 1030-1038.
17. Gutierrez-Juarez, R., A. Pocai, C. Mulas, H. Ono, S. Bhanot, B. P. Monia, and L. Rossetti. 2006. Critical role of stearoyl-CoA desaturase- 1 (SCD1) in the onset of diet-induced hepatic insulin resistance. J. Clin. Invest. 116: 1686-1695.
18. Savage, D. B., C. S. Choi, V. T. Samuel, Z. X. Liu, D. Zhang, A. Wang, X. M. Zhang, G. W. Cline, X. X. Yu, J. G. Geisler, et al. 2006 Reversal of diet-induced hepatic steatosis and hepatic insulin resistance by antisense oligonucleotide inhibitors of acetyl-CoA carboxylases 1 and 2. J. Clin. Invest. 116: 817-824.
19. Miyazaki, M., M. T. Flowers, H. Sampath, K. Chu, C. Otzelberger X. Liu, and J. M. Ntambi. 2007. Hepatic stearoyl-CoA desaturase-1 deficiency protects mice from carbohydrate-induced adiposity and hepatic steatosis. Cell Metab. 6: 484-496.
20. Sampath, H., M. Miyazaki, A. Dobrzyn, and J. M. Ntambi. 2007 Stearoyl-CoA desaturase-1 mediates the pro-lipogenic effects of dietary saturated fat. J. Biol. Chem. 282: 2483-2493.
21. Mao, J., F. J. DeMayo, H. Li, L. Abu-Elheiga, Z. Gu, T. E. Shaikenov P. Kordari, S. S. Chirala, W. C. Heird, and S. J. Wakil. 2006. Liver-specific deletion of acetyl-CoA carboxylase 1 reduces hepatic triglyceride accumulation without affecting glucose homeostasis. Proc. Natl. Acad. Sci. USA. 103: 8552-8557.
22. Chakravarthy, M. V., Z. Pan, Y. Zhu, K. Tordjman, J. G. Schneider T. Coleman, J. Turk, and C. F. Semenkovich. 2005. "New" hepatic fat activates PPARalpha to maintain glucose, lipid, and cholesterol homeostasis. Cell Metab. 1: 309-322.
23. Fukuda, H., A. Katsurada, and N. Iritani. 1992. Effects of nutrients and hormones on gene expression of ATP citrate-lyase in rat liver. Eur. J. Biochem. 209: 217-222.
24. Beigneux, A. P., C. Kosinski, B. Gavino, J. D. Horton, W. C. Skarnes and S. G. Young. 2004. ATP-citrate lyase deficiency in the mouse. J. Biol. Chem. 279: 9557-9564.
25. Bauer, D. E., G. Hatzivassiliou, F. Zhao, C. Andreadis, and C. B. Thompson. 2005. ATP citrate lyase is an important component of cell growth and transformation. Oncogene. 24: 6314-6322.
26. Hatzivassiliou, G., F. Zhao, D. E. Bauer, C. Andreadis, A. N. Shaw D. Dhanak, S. R. Hingorani, D. A. Tuveson, and C. B. Thompson 2005. ATP citrate lyase inhibition can suppress tumor cell growth. Cancer Cell. 8: 311-321. (Pubitemid 41443416)
27. Migita, T., T. Narita, K. Nomura, E. Miyagi, F. Inazuka, M. Matsuura M. Ushijima, T. Mashima, H. Seimiya, Y. Satoh, et al. 2008. ATP citrate lyase: activation and therapeutic implications in non-small cell lung cancer. Cancer Res. 68: 8547-8554.
28. Pearce, N. J., J. W. Yates, T. A. Berkhout, B. Jackson, D. Tew, H. Boyd, P. Camilleri, P. Sweeney, A. D. Gribble, A. Shaw, et al. 1998. The role of ATP citrate-lyase in the metabolic regulation of plasma lipids. Hypolipidaemic effects of SB-204990, a lactone prodrug of the potent ATP citrate-lyase inhibitor SB-201076. Biochem. J. 334: 113-119.
29. Preuss, H. G., C. V. Rao, R. Garis, J. D. Bramble, S. E. Ohia, M. Bagchi, and D. Bagchi. 2004. An overview of the safety and efficacy of a novel, natural(-)-hydroxycitric acid extract (HCA-SX) for weight management. J. Med. 35: 33-48.
30. Li, J. J., H. Wang, J. A. Tino, J. A. Robl, T. F. Herpin, R. M. Lawrence, S. Biller, H. Jamil, R. Ponticiello, L. Chen, et al. 2007. 2-Hydroxy- N-arylbenzenesulfonamides as ATP-citrate lyase inhibitors. Bioorg. Med. Chem. Lett. 17: 3208-3211.
31. Kornacker, M. S., and J. M. Lowenstein. 1965. Citrate and the conversion of carbohydrate into fat. The activities of citrate-cleavage enzyme and acetate thiokinase in livers of starved and re-fed rats. Biochem. J. 94: 209-215.
32. Wang, Q., L. Jiang, J. Wang, S. Li, Y. Yu, J. You, R. Zeng, X. Gao, L. Rui, W. Li, et al. 2009. Abrogation of hepatic ATP-citrate lyase protects against fatty liver and ameliorates hyperglycemia in leptin receptor-deficient mice. Hepatology. 49: 1166-1175.
33. Sheaff, R. C., H. M. Su, L. A. Keswick, and J. T. Brenna. 1995. Conversion of alpha-linolenate to docosahexaenoate is not depressed by high dietary levels of linoleate in young rats: tracer evidence using high precision mass spectrometry. J. Lipid Res. 36: 998-1008.
34. Lam, T. K. T., R. Gutierrez-Juarez, A. Pocai, S. Bhanot, P. Tso, G. J. Schwartz, and L. Rossetti. 2007. Brain glucose metabolism controls the hepatic secretion of triglyceride-rich lipoproteins. Nat. Med. 13: 171-180.
35. Nakamuta, M., B. H. Chang, E. Zsigmond, K. Kobayashi, H. Lei, B. Y. Ishida, K. Oka, E. Li, and L. Chan. 1996. Complete phenotypic characterization of apobec-1 knockout mice with a wild-type genetic background and a human apolipoprotein B transgenic background, and restoration of apolipoprotein B mRNA editing by somatic gene transfer of Apobec-1. J. Biol. Chem. 271: 25981-25988.
36. Davidson, N. O., and G. S. Shelness. 2000. Apolipoprotein B: mRNA editing, lipoprotein assembly, and presecretory degradation. Annu. Rev. Nutr. 20: 169-193.
37. Hirano, K., S. G. Young, R. V. Farese, Jr., J. Ng, E. Sande, C. Warburton, L. M. Powell-Braxton, and N. O. Davidson. 1996. Targeted disruption of the mouse apobec-1 gene abolishes apolipoprotein B mRNA editing and eliminates apolipoprotein B48. J. Biol. Chem. 271: 9887-9890.
38. Cao, H., K. Gerhold, J. R. Mayers, M. M. Wiest, S. M. Watkins, and G. S. Hotamisligil. 2008. Identification of a lipokine, a lipid hormone linking adipose tissue to systemic metabolism. Cell. 134: 933-944.
39. Miyazaki, M., Y-C. Kim, and J. M. Ntambi. 2001. A lipogenic diet in mice with a disruption of the stearoyl-CoA desaturase 1 gene reveals a stringent requirement of endogenous monounsaturated fatty acids for triglyceride synthesis. J. Lipid Res. 42: 1018-1024.
40. Sowden, M. P., N. Ballatori, K. L. Jensen, L. H. Reed, and H. C. Smith. 2002. The editosome for cytidine to uridine mRNA editing has a native complexity of 27S: identification of intracellular domains containing active and inactive editing factors. J. Cell Sci. 115: 1027-1039.
41. Wellen, K. E., G. Hatzivassiliou, U. M. Sachdeva, T. V. Bui, J. R. Cross, and C. B. Thompson. 2009. ATP-citrate lyase links cellular metabolism to histone acetylation. Science. 324: 1076-1080.
42. Lerin, C., J. T. Rodgers, D. E. Kalume, S. H. Kim, A. Pandey, and P. Puigserver. 2006. GCN5 acetyltransferase complex controls glucose metabolism through transcriptional repression of PGC-1alpha. Cell Metab. 3: 429-438. (Pubitemid 43811779)
43. Li, X., S. Zhang, G. Blander, J. G. Tse, M. Krieger, and L. Guarente. 2007. SIRT1 deacetylates and positively regulates the nuclear receptor LXR. Mol. Cell. 28: 91-106.
44. Kelly, T. J., C. Lerin, W. Haas, S. P. Gygi, and P. Puigserver. 2009. GCN5- mediated transcriptional control of the metabolic coactivator PGC- 1beta through lysine acetylation. J. Biol. Chem. 284: 19945-19952.